赛乐西帕中间体结构式
|
常用名 | 赛乐西帕中间体 | 英文名 | MRE-269 |
|---|---|---|---|---|
| CAS号 | 475085-57-5 | 分子量 | 419.516 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 602.1±55.0 °C at 760 mmHg | |
| 分子式 | C25H29N3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 318.0±31.5 °C |
赛乐西帕中间体用途MRE-269 是 selexipag 的有效代谢物,同时为选择性的 IP 受体激动剂。 |
| 中文名 | 赛乐西帕中间体 |
|---|---|
| 英文名 | {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid |
| 英文别名 | 更多 |
| 描述 | MRE-269 是 selexipag 的有效代谢物,同时为选择性的 IP 受体激动剂。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
IP Receptor |
| 体外研究 | MRE-269诱导大鼠外叶肺动脉(EPA)的内皮依赖性血管舒张。 MRE-269或其他IP受体激动剂包括依前列醇,伊洛前列素,曲前列环素和贝前列素可增加hPASMC中的cAMP水平[1]。 MRE-269在LPA(+),LPA(-)和SPA(-)中诱导浓度依赖性血管舒张[3]。 |
| 体内研究 | MRE-269对大鼠小叶内肺动脉(SIPA)和EPA的血管舒张作用相同,而其他IP受体激动剂在SIPA中诱导的血管舒张作用少于EPA [1]。 MRE-269可使大鼠小肺动脉显着松弛,但其效果仅在10μM以上的高浓度时才有效(pEC50,4.98±0.22)。相比之下,在大鼠小肺静脉中,MRE-269仅在整个浓度范围内产生最小的松弛,在10和100μM的两个最高剂量的MRE-269中仅发生显着的松弛[2]。 |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 602.1±55.0 °C at 760 mmHg |
| 分子式 | C25H29N3O3 |
| 分子量 | 419.516 |
| 闪点 | 318.0±31.5 °C |
| 精确质量 | 419.220886 |
| PSA | 75.55000 |
| LogP | 5.09 |
| InChIKey | OJQMKCBWYCWFPU-UHFFFAOYSA-N |
| SMILES | CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1 |
| 蒸汽压 | 0.0±1.8 mmHg at 25°C |
| 折射率 | 1.588 |
| 储存条件 | 2-8℃ |
| 赛乐西帕中间体上游产品 1 | |
|---|---|
| 赛乐西帕中间体下游产品 0 | |
|
实验名称:Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellula...
来源:ChEMBL
靶标:Gamma-aminobutyric acid receptor subunit alpha-1
External Id:CHEMBL5291801
|
|
实验名称:Thermal Shift Assay. Domain: start/stop: M1-L298
来源:ChEMBL
靶标:Cyclin-dependent kinase 2
External Id:CHEMBL5062802
|
|
实验名称:Binding affinity towards rat Gabra1 in an in vitro assay with cellular components mea...
来源:ChEMBL
靶标:Gamma-aminobutyric acid receptor subunit alpha-1
External Id:CHEMBL5291798
|
|
实验名称:Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measu...
来源:ChEMBL
靶标:Estrogen receptor
External Id:CHEMBL5291791
|
|
实验名称:Rat IP receptor (Prostanoid receptors)
来源:IUPHAR-DB
靶标:IP receptor (Prostanoid receptors) [Rattus norvegicus]
External Id:345_Rat
|
|
实验名称:Human EP2 receptor (Prostanoid receptors)
来源:IUPHAR-DB
靶标:EP2 receptor (Prostanoid receptors) [Homo sapiens]
External Id:341_Human
|
|
实验名称:Binding affinity towards human EDNRA in an in vitro assay with cellular components me...
来源:ChEMBL
靶标:Endothelin-1 receptor
External Id:CHEMBL5291785
|
|
实验名称:Binding affinity towards human DRD2 in an in vitro assay with cellular components mea...
来源:ChEMBL
靶标:D(2) dopamine receptor
External Id:CHEMBL5291781
|
|
实验名称:A screen for small molecules that modulate mitochondrial supercomplex formation
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1482
|
|
实验名称:Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resol...
来源:ChEMBL
靶标:D(1A) dopamine receptor
External Id:CHEMBL5291777
|
| MRE-269 |
| 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID |
| 2-(4-{[(3,5-dichlorophenyl)carbamoyl]amino}phenoxy)-2-methylpropanoic acid |
| {4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid |
| {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid |
| 4-(3,5-dichlorophenylureido)phenoxyisobutyric acid |
| {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid |
| ACT-333679 |
| 2-<4<<<(3,5-dichlorophenyl)amino>carbonyl>amino>phenoxy>-2-methylpropionic acid |
| 2-{4-[N'-(3,5-dichlorophenyl)ureido]phenoxy}isobutyric acid |
| 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid |
| Propanoic acid,2-[4-[[[(3,5-dichlorophenyl)amino]carbonyl]amino]phenoxy]-2-methyl |